Endovia secures $500,000 convertible financing for CannEpil
TipRanks (Tue, 22-Sep 4:28 PM ET)
Globe Newswire (Tue, 22-Sep 9:30 AM ET)
Globe Newswire (Mon, 31-Aug 8:30 AM ET)
Globe Newswire (Tue, 25-Aug 8:30 AM ET)
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.
Endovia Health Sciences trades on the AMEX stock market under the symbol EDVA.
As of September 22, 2026, EDVA stock price declined to $0.23 with 380,916 million shares trading.
EDVA has a market cap of $1.60 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that EDVA belongs to (by Net Assets): VXF.
EDVA support price is $.22 and resistance is $.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDVA shares will trade within this expected range on the day.